LifeStance Health Group LFST
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Key Insights
LifeStance Health Group (LFST) Core Market Data and Business Metrics
Latest Closing Price
$6.63Total Outstanding Shares
384.55 Million SharesDividend
No dividendSIC Description
Services-health ServicesPrimary Exchange
NASDAQHeadquarters
4800 N. Scottsdale Road, Scottsdale, AZ, 85251
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
| Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
|---|---|---|---|
| 2,171,492 Shares | 3.56 | 3/14/2025 | 7,730,317 Shares |
| 2,273,611 Shares | 3.69 | 2/28/2025 | 8,398,230 Shares |
| 576,493 Shares | 15.35 | 2/14/2025 | 8,846,503 Shares |
| 962,264 Shares | 9.56 | 1/31/2025 | 9,194,561 Shares |
| 1,178,037 Shares | 8.3 | 1/15/2025 | 9,778,439 Shares |
| 1,271,560 Shares | 7.75 | 12/31/2024 | 9,856,729 Shares |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Financing Activities | $-9.95 Million |
| Net Cash Flow | $75.75 Million |
| Net Cash Flow From Operating Activities | $107.26 Million |
| Net Cash Flow From Investing Activities | $-21.57 Million |
| Net Cash Flow From Operating Activities, Continuing | $107.26 Million |
| Net Cash Flow From Financing Activities, Continuing | $-9.95 Million |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Income Tax Expense/Benefit | $-170,000 |
| Selling, General, and Administrative Expenses | $363.06 Million |
| Income Tax Expense/Benefit, Deferred | $-958,000 |
| Net Income/Loss | $-57.44 Million |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0 |
| Net Income/Loss Available To Common Stockholders, Basic | $-57.44 Million |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss Attributable To Parent | $-58.82 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
| Other Comprehensive Income/Loss | $-1.37 Million |
| Comprehensive Income/Loss | $-58.82 Million |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Liabilities And Equity | $2.12 Billion |
| Current Liabilities | $228.89 Million |
| Other Non-current Assets | $1.45 Billion |
| Intangible Assets | $190.80 Million |
| Fixed Assets | $166.04 Million |
| Wages | $117.46 Million |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||